FICS GENESIS Trademark

Trademark Overview

On Friday, November 22, 2024, a trademark application was filed for FICS GENESIS with the United States Patent and Trademark Office. The USPTO has given the FICS GENESIS trademark a serial number of 98868280. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, November 22, 2024. This trademark is owned by PI Health USA, LLC. The FICS GENESIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software development, programming and implementation, medical and pharmacological research services, and conducting clinic trials for others.
fics genesis

General Information

Serial Number98868280
Word MarkFICS GENESIS
Filing DateFriday, November 22, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, November 22, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesSoftware development, programming and implementation, medical and pharmacological research services, and conducting clinic trials for others.

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 22, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePI Health USA, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Friday, November 22, 2024NEW APPLICATION ENTERED

Related Keywords

genesis fics conducting services clinic trials others research pharmacological development programming implementation